NJBIZ15h
Medtech mindset: BD plans to divest diagnostic, biosciences divisions
According to the company, medical essentials and interventional lead the medical technology unit's business lines, bringing ...
BD (Becton, Dickinson and Company): BD Reports First Quarter Fiscal 2025 Financial Results
Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic ...
New Jersey Business4d
BD Intends to Separate Biosciences and Diagnostic Solutions Business
The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD ...
Becton, Dickinson and Company (BDX) Stock Forecasts
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled ...
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...
PharmiWeb5d
GCC Syringes and Needles Market Poised for Steady Growth USD 1,164.90 Million at a 5.40% of CAGR
Syringes and Needles MarketThe sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to ...